Literature DB >> 20043146

The association between substance misuse and first-episode psychosis in a defined UK geographical area during the 1990s.

Kim Donoghue1, Ian Medley, John Brewin, Cristine Glazebrook, Peter Mason, Roch Cantwell, Peter B Jones, Glynn Harrison, Gillian A Doody.   

Abstract

OBJECTIVE: The aim of this study was to examine the prevalence of all substance use disorders (SUD) and cannabis-specific SUDs reported in two first-episode epidemiological studies, conducted in the same catchment area, 5 years apart.
METHODS: The prevalence of schizophrenia in Nottingham and Aetiology and Ethnicity of Schizophrenia and Other Psychoses studies included all people with a first-episode of psychosis between 1992 and 1994 and 1997 and 1999, respectively. Those individuals with a comorbid diagnosis of a SUD (ICD-10 harmful use or dependence) were identified.
RESULTS: An upward (but not statistically significant) trend in all SUDs was found for the first-episode study population as a whole, between the two cohorts (11.9-18.2%). When analysed by age, a significant increase in cannabis-specific SUDs was observed for all first-episode cases aged 16-29 between cohorts (3.2-10.6%). When analysed by age and gender, a significant increase in all SUDs was apparent for female first-episode patients aged 16-29 between cohorts (6.1-24.2%), this same increase was not seen in male patients.
CONCLUSIONS: Illegal drug misuse is common in patients with a first-episode of psychosis. However, most concerning is that when both age and gender are considered, females with a first-episode of psychosis aged 16-29 show a highly significant rise in the prevalence of all SUDs over the 1990s. More recent drug use data from England and Wales shows that the prevalence of drug use in the 21st century is declining; further epidemiological studies are required to determine whether this is also the case in young female first-episode psychosis populations.

Entities:  

Mesh:

Year:  2009        PMID: 20043146     DOI: 10.1007/s00127-009-0175-5

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  31 in total

1.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

2.  Substance abuse and the onset of schizophrenia.

Authors:  M Hambrecht; H Häfner
Journal:  Biol Psychiatry       Date:  1996-12-01       Impact factor: 13.382

3.  Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study.

Authors:  A Jablensky; N Sartorius; G Ernberg; M Anker; A Korten; J E Cooper; R Day; A Bertelsen
Journal:  Psychol Med Monogr Suppl       Date:  1992

Review 4.  Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review.

Authors:  Giuseppe Carrà; Sonia Johnson
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-11-13       Impact factor: 4.328

5.  Cannabis abuse and the course of recent-onset schizophrenic disorders.

Authors:  D H Linszen; P M Dingemans; M E Lenior
Journal:  Arch Gen Psychiatry       Date:  1994-04

6.  Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.

Authors:  David J Potter; Peter Clark; Marc B Brown
Journal:  J Forensic Sci       Date:  2008-01       Impact factor: 1.832

7.  Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.

Authors:  J Rabinowitz; E J Bromet; J Lavelle; G Carlson; B Kovasznay; J E Schwartz
Journal:  Psychol Med       Date:  1998-11       Impact factor: 7.723

Review 8.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

9.  The incidence of schizophrenia in Nottingham.

Authors:  J E Cooper; D Goodhead; T Craig; M Harris; J Howat; J Korer
Journal:  Br J Psychiatry       Date:  1987-11       Impact factor: 9.319

10.  Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.

Authors:  Matthew Hickman; Peter Vickerman; John Macleod; James Kirkbride; Peter B Jones
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

View more
  3 in total

1.  Incidence of hospitalised schizophrenia in Finland since 1980: decreasing and increasing again.

Authors:  Raimo K R Salokangas; Mika Helminen; Anna-Maija Koivisto; Helena Rantanen; Hannu Oja; Sami Pirkola; Kristian Wahlbeck; Matti Joukamaa
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2010-03-20       Impact factor: 4.328

2.  Modelling the emergence of hallucinations: early acquired vulnerabilities, proximal life stressors and maladaptive psychological processes.

Authors:  Eliot Goldstone; John Farhall; Ben Ong
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-11-02       Impact factor: 4.328

Review 3.  Dissecting Molecular Genetic Mechanisms of 1q21.1 CNV in Neuropsychiatric Disorders.

Authors:  Joy Yoon; Yingwei Mao
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.